Details for New Drug Application (NDA): 080660
✉ Email this page to a colleague
NDA 080660 describes OCUSULF-30, which is a drug marketed by Miza Pharms Usa and is included in one NDA. Additional details are available on the OCUSULF-30 profile page.
The generic ingredient in OCUSULF-30 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
The generic ingredient in OCUSULF-30 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 080660
| Tradename: | OCUSULF-30 |
| Applicant: | Miza Pharms Usa |
| Ingredient: | sulfacetamide sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080660
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 30% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
